Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to seek emergency use of limited shot supplies as the catastrophic outbreak worsens across the globe. The announcement from...
Volunteers Still Needed to Test Variety of COVID-19 Vaccines
Two COVID-19 vaccines might be nearing the finish line, but scientists caution it's critical that enough people volunteer to help finish studying other candidates in the U.S. and around the world. Moderna Inc. and competitor Pfizer Inc. recently announced preliminary results showing their vaccines appear more than 90% effective, at least for...
2nd Virus Vaccine Shows Overwhelming Success in US Tests
Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide. The company said its vaccine appears...
Testing Timeline: What’s Ahead for COVID-19 Vaccines
Pfizer's surprising news that its COVID-19 vaccine might offer more protection than anticipated — an announcement right after a fraught U.S. presidential election campaign — is raising questions about exactly how the different shots will make it to market. Pfizer Inc. and the maker of the other leading U.S. vaccine candidate,...
Biden Cheers Vaccine Progress but Says Masks Remain a Must
WILMINGTON — President-elect Joe Biden on Monday cheered news about the promising development of a coronavirus vaccine but cautioned Americans need to be aggressive about mask wearing and social distancing as infections continue to surge around the country. The Democrat's transition team also unveiled members of Biden's coronavirus working group...
Pfizer Says COVID-19 Vaccine Is Looking 90% Effective
Pfizer said Monday that an early peek at the data on its coronavirus vaccine suggests the shots may be a surprisingly robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration. The announcement, less than...
Stocks Burst Higher, S&P 500 at Record on Vaccine Hopes
NEW YORK — Stocks are surging Monday, catapulting Wall Street back to record heights, on a burst of hope following encouraging data about a potential COVID-19 vaccine. The S&P 500 was 3.3% higher in morning trading after Pfizer said an early peek at its vaccine data suggests the shots may be...
Next up in Hunt for COVID-19 Vaccine: Testing Shots in Kids
The global hunt for a COVID-19 vaccine for kids is only just beginning — a lagging start that has some U.S. pediatricians worried they may not know if any shots work for young children in time for the next school year. Older adults may be most vulnerable to the coronavirus,...
COVID Vaccine Available in Mid-November at Earliest, Company Says.
NEW YORK — Pfizer Inc. cannot request emergency authorization of its COVID-19 vaccine before the third week of November -- and that’s if everything goes well, the company’s CEO announced Friday. Despite President Donald Trump’s repeated promises of a vaccine before Election Day, scientists have been cautioning that it’s unlikely...
Health Officials Worry U.S. Not Ready for COVID-19 Vaccine
Millions of Americans are counting on a COVID-19 vaccine to curb the global pandemic and return life to normal. While one or more options could be available toward the end of this year or early next, the path to delivering vaccines to 330 million people remains unclear for the local health officials...